Moderna (MRNA)

Investing Cash Flow

$329.00M

Quarterly · Period ending: · USD

MRNA logo

MRNA Investing Cash Flow

Latest reported$329.00M
MRNA Quarterly Cash from Investing ($144.26M → $329.00M)
High-resolution chart · PNG

MRNA investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
329,000,000
-76,000,000
-48,000,000
700,000,000
564,000,000
730,000,000
-539,000,000
721,000,000
1,649,000,000
118,000,000
-538,000,000
789,000,000
1,944,000,000
2,011,000,000
-1,048,000,000
945,000,000
-1,152,000,000
-3,921,000,000
-1,138,000,000
-3,327,000,000
-3,878,000,000
-180,000,000
-190,129,000
-1,178,260,000
13,000,000
-316,018,000
130,348,000
113,367,000
-246,901,000
-11,759,000
6,409,000
116,468,000
-11,645,000
-483,704,000
112,799,000
14,774,000
144,261,000
144,261,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.